These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The effect of single administration of intravenous ketamine augmentation on suicidal ideation in treatment-resistant unipolar depression: Results from a randomized double-blind study. Feeney A; Hock RS; Freeman MP; Flynn M; Hoeppner B; Iosifescu DV; Trivedi MH; Sanacora G; Mathew SJ; Debattista C; Ionescu DF; Fava M; Papakostas GI Eur Neuropsychopharmacol; 2021 Aug; 49():122-132. PubMed ID: 34090255 [TBL] [Abstract][Full Text] [Related]
6. Ketamine metabolite pilot study in a suicidal depression trial. Grunebaum MF; Galfalvy HC; Choo TH; Parris MS; Burke AK; Suckow RF; Cooper TB; Mann JJ J Psychiatr Res; 2019 Oct; 117():129-134. PubMed ID: 31415914 [TBL] [Abstract][Full Text] [Related]
7. Urgent ketamine infusion rapidly eliminated suicidal ideation for a patient with major depressive disorder: a case report. Zigman D; Blier P J Clin Psychopharmacol; 2013 Apr; 33(2):270-2. PubMed ID: 23422387 [No Abstract] [Full Text] [Related]
8. Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial. Ionescu DF; Bentley KH; Eikermann M; Taylor N; Akeju O; Swee MB; Pavone KJ; Petrie SR; Dording C; Mischoulon D; Alpert JE; Brown EN; Baer L; Nock MK; Fava M; Cusin C J Affect Disord; 2019 Jan; 243():516-524. PubMed ID: 30286416 [TBL] [Abstract][Full Text] [Related]
9. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder. DiazGranados N; Ibrahim LA; Brutsche NE; Ameli R; Henter ID; Luckenbaugh DA; Machado-Vieira R; Zarate CA J Clin Psychiatry; 2010 Dec; 71(12):1605-11. PubMed ID: 20673547 [TBL] [Abstract][Full Text] [Related]
10. Intravenous Ketamine as an Effective and Safe Treatment in a Suicidal Patient With Cancer Who Was Nil Per Os. Rajagukguk S; Lee T Psychosomatics; 2020; 61(4):371-374. PubMed ID: 31739996 [No Abstract] [Full Text] [Related]
11. Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial. Murrough JW; Soleimani L; DeWilde KE; Collins KA; Lapidus KA; Iacoviello BM; Lener M; Kautz M; Kim J; Stern JB; Price RB; Perez AM; Brallier JW; Rodriguez GJ; Goodman WK; Iosifescu DV; Charney DS Psychol Med; 2015 Dec; 45(16):3571-80. PubMed ID: 26266877 [TBL] [Abstract][Full Text] [Related]
12. Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study. Ionescu DF; Swee MB; Pavone KJ; Taylor N; Akeju O; Baer L; Nyer M; Cassano P; Mischoulon D; Alpert JE; Brown EN; Nock MK; Fava M; Cusin C J Clin Psychiatry; 2016 Jun; 77(6):e719-25. PubMed ID: 27232360 [TBL] [Abstract][Full Text] [Related]
13. Ketamine rapidly relieves acute suicidal ideation in cancer patients: a randomized controlled clinical trial. Fan W; Yang H; Sun Y; Zhang J; Li G; Zheng Y; Liu Y Oncotarget; 2017 Jan; 8(2):2356-2360. PubMed ID: 27926528 [TBL] [Abstract][Full Text] [Related]
14. The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis. Wilkinson ST; Ballard ED; Bloch MH; Mathew SJ; Murrough JW; Feder A; Sos P; Wang G; Zarate CA; Sanacora G Am J Psychiatry; 2018 Feb; 175(2):150-158. PubMed ID: 28969441 [TBL] [Abstract][Full Text] [Related]
15. Recurrent Suicidal Ideation During Intravenous Ketamine Treatment. Smith AWT; Virk S Am J Ther; 2019; 26(6):e732-e735. PubMed ID: 30946043 [No Abstract] [Full Text] [Related]
16. Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial. Dwyer JB; Landeros-Weisenberger A; Johnson JA; Londono Tobon A; Flores JM; Nasir M; Couloures K; Sanacora G; Bloch MH Am J Psychiatry; 2021 Apr; 178(4):352-362. PubMed ID: 33653121 [TBL] [Abstract][Full Text] [Related]
17. Role of Ketamine in Severe Depression with suicidal ideation - Insights from a Case Study. Gurnani T; Khurshid KA Asian J Psychiatr; 2017 Oct; 29():112-113. PubMed ID: 29061405 [No Abstract] [Full Text] [Related]
18. Effects of Mu-Opiate Receptor Gene Polymorphism rs1799971 (A118G) on the Antidepressant and Dissociation Responses in Esketamine Nasal Spray Clinical Trials. Saad Z; Hibar D; Fedgchin M; Popova V; Furey ML; Singh JB; Kolb H; Drevets WC; Chen G Int J Neuropsychopharmacol; 2020 Dec; 23(9):549-558. PubMed ID: 32367114 [TBL] [Abstract][Full Text] [Related]
19. Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials. Ballard ED; Wills K; Lally N; Richards EM; Luckenbaugh DA; Walls T; Ameli R; Niciu MJ; Brutsche NE; Park L; Zarate CA J Affect Disord; 2017 Aug; 218():195-200. PubMed ID: 28477497 [TBL] [Abstract][Full Text] [Related]
20. Effects of Ketamine Versus Midazolam on Neurocognition at 24 Hours in Depressed Patients With Suicidal Ideation. Keilp JG; Madden SP; Marver JE; Frawley A; Burke AK; Herzallah MM; Gluck M; Mann JJ; Grunebaum MF J Clin Psychiatry; 2021 Nov; 82(6):. PubMed ID: 34727422 [No Abstract] [Full Text] [Related] [Next] [New Search]